Altimmune Inc 주식(ALT)의 최신 뉴스
Altimmune Inc (ALT) produces promising results – US Post News - US Post News
US Post News
ALTIMMUNE, INC. (NASDAQ: ALT) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Altimmune, Inc. Investors of ... - GlobeNewswire
GlobeNewswire
Altimmune, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before July 5, 2024 to ... - PR Newswire
PR Newswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
GlobeNewswire
3 Reasons Why Altimmune Stock Could Be the Next Viking Therapeutics - sharewise
sharewise
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune - Markets Insider
Markets Insider
3 Reasons Why Altimmune Stock Could Be the Next Viking Therapeutics - Yahoo Finance
Yahoo Finance
Head-To-Head Review: Altimmune (NASDAQ:ALT) & Zymeworks (NYSE:ZYME) - Defense World
Defense World
ALT Deadline: ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit - PR Newswire
PR Newswire
If These 3 Words Are True, Altimmune's Weight Loss Candidate Could Beat Novo Nordisk's Wegovy
The Motley Fool
Lost Money on Altimmune, Inc.(ALT)? Join Class Action Suit Seeking Recovery – Contact The Gross Law Firm - The Malaysian Reserve
The Malaysian Reserve
Class Action Lawsuit against Altimmune, Inc. (NASDAQ:ALT) - MSN
MSN
Altimmune Inc (ALT)'s Day in Review: Closing at 6.39, Up by 2.08 – DWinneX - The Dwinnex
The Dwinnex
Class Action Lawsuit against Altimmune, Inc. (NASDAQ:ALT) - TipRanks.com - TipRanks
TipRanks
Class Action Lawsuit against Altimmune, Inc. (NASDAQ:ALT) - TipRanks.com - TipRanks
TipRanks
Deadline on July 5th coming up in Lawsuit for Investors in Altimmune, Inc. (NASDAQ: ALT) - openPR
openPR
Altimmune, Inc. (ALT): Why Are Hedge Funds Shorting This Biopharmaceutical Stock? - Insider Monkey
Insider Monkey
Altimmune, Inc. (ALT): Why Are Hedge Funds Shorting This Biopharmaceutical Stock? - Yahoo Finance
Yahoo Finance
Deadline on July 5th coming up in Lawsuit for Investors in Altimmune, Inc. (NASDAQ: ALT) - openPR
openPR
No longer a two-horse race: Obesity drug competition expands - BioWorld Online
BioWorld Online
IMMINENT ALT DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Altimmune, Inc. Investors to Join the Class ... - AccessWire
AccessWire
Altimmune Stock Is Rising Monday: What's Driving The Action? - MSN
MSN
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune - The Malaysian Reserve
The Malaysian Reserve
Long Term Trading Analysis for (ALT) - Stock Traders Daily
Stock Traders Daily
Why Are Altimmune Shares Trading Lower Wednesday? - Altimmune (NASDAQ:ALT) - Benzinga
Benzinga
Altimmune Drops 15% After Sudden Death of Finance Chief - MarketWatch
MarketWatch
Dime Community Bancshares sets $65M subordinated notes offer By Investing.com - Investing.com
Investing.com
Altimmune CFO Richard Eisenstadt passes away By Investing.com - Investing.com Australia
Investing.com Australia
Altimmune CFO Richard Eisenstadt passes away By Investing.com - Investing.com
Investing.com
Altimmune CFO Richard Eisenstadt passes away By Investing.com - Investing.com UK
Investing.com UK
A look into Altimmune Inc (ALT)'s deeper side – Sete News - SETE News
SETE News
Altimmune CFO Richard Eisenstadt passes away unexpectedly - MM+M Online
MM+M Online
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Altimmune ... - GlobeNewswire
GlobeNewswire
Holzer & Holzer, LLC Reminds Shareholders of July 5, 2024 Lead Plaintiff Deadline in Altimmune, Inc. (ALT) Class ... - GlobeNewswire
GlobeNewswire
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune - PR Newswire
PR Newswire
Altimmune Appoints Andrew Shutterly as New CFO - TipRanks.com - TipRanks
TipRanks
Altimmune Chief Financial Officer Richard Eisenstadt Dies - MarketWatch
MarketWatch
Altimmune CFO Richard Eisenstadt passes away (NASDAQ:ALT) - Seeking Alpha
Seeking Alpha
Altimmune Mourns Passing of Chief Financial Officer, Richard Eisenstadt - StockTitan
StockTitan
Altimmune Mourns Passing of Chief Financial Officer, Richard Eisenstadt - Yahoo Finance
Yahoo Finance
IMMINENT ALT DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Altimmune, Inc. Investors to Join the Class ... - AccessWire
AccessWire
Contact Levi & Korsinsky by July 5, 2024 Deadline to Join Class Action Against Altimmune, Inc.(ALT) - PR Newswire
PR Newswire
Altimmune (NASDAQ:ALT) Given “Buy” Rating at B. Riley - Defense World
Defense World
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
GlobeNewswire
Altimmune Target of Unusually Large Options Trading (NASDAQ:ALT) - Defense World
Defense World
Short ALT: Altimmune Inc. faces bearish rejection at major resistance, targeting recent lows - Invezz
Invezz
IMMINENT ALT DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Altimmune, Inc. Investors to Join the Class ... - AccessWire
AccessWire
Shareholders that lost money on Altimmune, Inc.(ALT) should contact The Gross Law Firm about pending Class Action ... - Marketscreener.com
Marketscreener.com
Shareholders that lost money on Altimmune, Inc.(ALT) should contact The Gross Law Firm about pending Class Action ... - PR Newswire
PR Newswire
ADA 2024: Altimmune's GLP-1 drug shows weight loss potential - Clinical Trials Arena
Clinical Trials Arena
자본화:
|
볼륨(24시간):